Table 1 Characteristics of patients who responded to the Internet survey and self-reported a physician diagnosis of gout (N = 499)

Age, mean ± SD (range)

497

56.3 ± 12.6 (25–93)

Age groups, %

   21–40

61

12.2

   41–60

244

48.9

   61–80

179

35.9

   ≥80

13

2.6

   Missing

2

0.4

Sex, %

   Male

368

73.7

   Female

131

26.3

Race, %

   White/Caucasian

371

74.3

   African American

38

7.6

   Hispanic or Latino

14

2.8

   Asian

45

9.0

   American Indian or Alaskan Native

3

0.6

   Hawaiian or Pacific Islander

9

1.8

   Other

18

3.6

   Missing

1

0.2

Patients prescribed Allopurinol/Febuxostat, %

285

57.1

Number of days gout medication missed in past 30 days, mean ± S.D.

251

4.50 ± 8.72

Of those prescribed ULT, n/N (%)

   On ULT

250/285

88

   Quit ULT

20/285

7

   Taking ULT infrequently

2/285

0.7

   Missing/did not respond

13/285

4.5

Days ULT missed in past 30 days, n/N (%)

   0 days (adherence 100 %)

148/251

59

   1–5 days (adherence >80 %)

49/251

19.5

   6–14 days (adherence, 51–80 %)

26/251

10.3

   >15 days (adherence, ≤50 %)

28/251

11.2

Best life-long treatment choice, %

   Cherry extract

122

24.4

   Diet modification

79

15.8

   ULT

277

55.5

   None

21

4.2

Likelihood of making life-long change to diet (0–10), %

   0–8

308

61.7

   9–10

191

38.3